IE Pharmaceuticals

Perrigo Company PLC (PRGO)

Track

Perrigo Company PLC experienced one notable insider trading transaction during the past ninety days, involving a proposed sale of shares by a former director. This activity follows a period where the stock price appreciated by nineteen percent, occurring after the most recent earnings report showed a significant positive surprise in per-share performance.
Ticker: PRGO Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Proposed sale 28 May 2026
Value US$2,445,147.18 | Price 240.47 | Shares 40,906
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-28 2026-05-28 PrS Proposed sale
2.4
KINDLER JEFFREY B

Former Director

Non-Executive Director
40,906
240.47
US$2,445,147 		40,906 240.47 US$2,445,147
2025-11-14 2025-11-12 B Purchase
1.9
Parker Geoffrey M.
Non-Executive Director
31,895 +49.9%
262.20
US$737,683 		31,895 +49.9% 262.20 US$737,683
2025-09-10 2025-09-08 B Purchase
0.7
Lennox Abigail

EVP and CSO

Officer
95,479 -9.0%
102.37
US$3,853,122 		95,479 -9.0% 102.37 US$3,853,122
2025-09-09 2025-09-05 B Purchase
0.6
Atkinson Charles

EVP, General Counsel & Sec.

Officer
1,000 +inf%
23.20
US$23,200 		1,000 +inf% 23.20 US$23,200
2025-08-22 2025-08-22 B Purchase
3.1
Willis Robert

EVP & CHRO

Officer
1,488 +3.7%
24.10
US$35,858 		1,488 +3.7% 24.10 US$35,858
2025-08-19 2025-08-18 B Purchase
1.9
Parker Geoffrey M.
Non-Executive Director
4,375 +15.1%
22.97
US$100,497 		4,375 +15.1% 22.97 US$100,497
2025-08-19 2025-08-18 B Purchase
2.9
Bezerra Eduardo Guarita

EVP & Chief Financial Officer

Officer
3,000 +6.5%
22.74
US$68,207 		3,000 +6.5% 22.74 US$68,207
2025-08-08 2025-08-08 B Purchase
3.2
Lockwood-Taylor Patrick

CEO

Executive Director
54 +0.1%
22.37
US$1,208 		54 +0.1% 22.37 US$1,208
2025-08-08 2025-08-08 B Purchase
3.2
Lockwood-Taylor Patrick

CEO

Executive Director
346 +0.4%
22.38
US$7,743 		346 +0.4% 22.38 US$7,743
2025-08-08 2025-08-08 B Purchase
3.2
Lockwood-Taylor Patrick

CEO

Executive Director
4,060 +5.0%
22.37
US$90,815 		4,060 +5.0% 22.37 US$90,815
2025-06-05 2025-06-05 PrS Proposed sale
2.4
Doyle Katherine C.

Former Director

Non-Executive Director
11,159
26.21
US$292,477 		11,159 26.21 US$292,477
2025-05-14 2025-05-12 B Purchase
1.9
Parker Geoffrey M.
Non-Executive Director
3,500 +17.3%
27.10
US$94,850 		3,500 +17.3% 27.10 US$94,850
2025-03-10 2025-03-10 PrS Proposed sale
3.5
Janish Ronald Craig

Officer

Officer
7,800
27.44
US$214,032 		7,800 27.44 US$214,032
2025-03-10 2025-03-10 S Sale
3.5
Janish Ronald Craig

EVP, Gbl Ops & SC & CTO

Officer
7,800 -18.8%
27.44
US$214,032 		7,800 -18.8% 27.44 US$214,032
2025-03-03 2025-03-03 PrS Proposed sale
2.2
Andersen Svend

Officer

Officer
27,000
29.53
US$797,369 		27,000 29.53 US$797,369
2025-03-03 2025-03-03 PrS Proposed sale
2.2
Andersen Svend

Former Officer

Officer
17,343
30.30
US$525,416 		17,343 30.30 US$525,416
2024-12-10 2024-12-09 S Sale
2.4
KINDLER JEFFREY B
Non-Executive Director
17,598 -76.5%
28.27
US$497,495 		17,598 -76.5% 28.27 US$497,495
2024-12-09 2024-12-09 PrS Proposed sale
2.4
KINDLER JEFFREY B

Director

Non-Executive Director
17,598
28.27
US$497,426 		17,598 28.27 US$497,426
2024-09-13 2024-09-13 PrS Proposed sale
2.4
Doyle Katherine C.

Director

Non-Executive Director
8,954
27.30
US$244,444 		8,954 27.30 US$244,444
2024-09-13 2024-09-13 S Sale
2.4
Doyle Katherine C.
Non-Executive Director
8,954 -59.8%
27.30
US$244,444 		8,954 -59.8% 27.30 US$244,444
2024-08-28 2024-08-26 S Sale
3.5
Janish Ronald Craig

EVP, Gbl Ops & SC & CTO

Officer
13,000 -38.7%
29.40
US$382,246 		13,000 -38.7% 29.40 US$382,246
2024-08-28 2024-08-26 S Sale
3.5
Janish Ronald Craig

EVP, Gbl Ops & SC & CTO

Officer
13,000 -38.7%
29.40
US$382,246 		13,000 -38.7% 29.40 US$382,246
2024-08-26 2024-08-26 PrS Proposed sale
3.5
RONALD CRAIG JANISH

Insider / Exec VP of Global Ops
13,000
29.40
US$382,246 		13,000 29.40 US$382,246
2024-08-21 2024-08-20 S Sale
2.2
Andersen Svend

EVP & President CHCI

Officer
6,683 -48.8%
27.43
US$183,281 		6,683 -48.8% 27.43 US$183,281
2024-08-21 2024-08-20 S Sale
2.2
Andersen Svend

EVP & President CHCI

Officer
7,800 -9.6%
27.46
US$214,149 		7,800 -9.6% 27.46 US$214,149
2024-08-21 2024-08-20 S Sale
2.2
Andersen Svend

EVP & President CHCI

Officer
20,500 -20.1%
27.86
US$571,130 		20,500 -20.1% 27.86 US$571,130
2024-08-20 2024-08-20 PrS Proposed sale
2.2
Andersen Svend

Officer

Officer
20,500
27.86
US$571,130 		20,500 27.86 US$571,130
2024-08-07 2024-08-07 PrS Proposed sale
2.6
HANSON KYLE

Officer

Officer
1,890
28.40
US$53,667 		1,890 28.40 US$53,667
2024-06-11 2024-06-11 PrS Proposed sale
2.6
HANSON KYLE

Former Officer

Officer
11,137
28.25
US$314,610 		11,137 28.25 US$314,610
2024-05-31 2024-05-28 B Purchase
2.2
Andersen Svend

EVP & President CHCI

Officer
1,000 +1.0%
27.90
US$27,900 		1,000 +1.0% 27.90 US$27,900
2024-05-17 2024-05-17 PrS Proposed sale
2.8
Farrington Thomas

Former Officer

Officer
7,910
30.02
US$237,476 		7,910 30.02 US$237,476
2024-05-10 2024-05-10 PrS Proposed sale
2.8
Farrington Thomas

Officer

Officer
12,208
30.64
US$374,091 		12,208 30.64 US$374,091
2024-03-07 2024-03-05 B Purchase
3.2
Ives Alison

EVP & Chief Scientific Officer

Officer
2,490 +18.3%
27.26
US$67,877 		2,490 +18.3% 27.26 US$67,877
2024-03-01 2024-03-01 B Purchase
3.1
Willis Robert

EVP & CHRO

Officer
371 +1.5%
26.30
US$9,757 		371 +1.5% 26.30 US$9,757
2024-03-07 2024-02-29 B Purchase
3.2
Ives Alison

EVP & Chief Scientific Officer

Officer
1,545 +14.2%
26.44
US$40,850 		1,545 +14.2% 26.44 US$40,850
2024-03-01 2024-02-29 B Purchase
3.1
Willis Robert

EVP & CHRO

Officer
6,000 +31.4%
25.87
US$155,220 		6,000 +31.4% 25.87 US$155,220
2024-02-29 2024-02-29 B Purchase
3.2
Lockwood-Taylor Patrick

CEO

Executive Director
9,500 +86.4%
26.54
US$252,168 		9,500 +86.4% 26.54 US$252,168
2024-01-11 2024-01-09 PrS Proposed sale
3.0
Dillard James E III

Former Officer

Officer
2,900
33.69
US$97,712 		2,900 33.69 US$97,712
2023-11-27 2023-11-24 B Purchase
3.1
Willis Robert

EVP & CHRO

Officer
5,550 +40.9%
31.01
US$172,106 		5,550 +40.9% 31.01 US$172,106
2023-11-17 2023-11-16 B Purchase
3.2
Ives Alison

EVP & Chief Scientific Officer

Officer
2,040 +24.5%
29.34
US$59,854 		2,040 +24.5% 29.34 US$59,854
2023-11-15 2023-11-14 B Purchase
2.9
Bezerra Eduardo Guarita

EVP & Chief Financial Officer

Officer
5,000 +145.9%
29.18
US$145,882 		5,000 +145.9% 29.18 US$145,882
2023-11-14 2023-11-14 B Purchase
3.2
Lockwood-Taylor Patrick

CEO

Executive Director
11,000 +inf%
28.99
US$318,868 		11,000 +inf% 28.99 US$318,868
2023-06-14 2023-06-13 B Purchase
1.9
Parker Geoffrey M.
Non-Executive Director
10,000 +63.0%
33.06
US$330,637 		10,000 +63.0% 33.06 US$330,637
2023-05-25 2023-05-23 B Purchase
2.2
Andersen Svend

EVP & President CHCI

Officer
2,900 +4.4%
33.41
US$96,902 		2,900 +4.4% 33.41 US$96,902
2023-05-15 2023-05-11 S Sale
1.8
KESSLER MURRAY S

CEO

Executive Director
197,646 -98.7%
35.75
US$7,066,358 		197,646 -98.7% 35.75 US$7,066,358
2023-05-11 2023-05-11 PrS Proposed sale
1.8
MURRAY S. KESSLER

Officer; Director

Executive Director
197,646
35.75
US$7,066,358 		197,646 35.75 US$7,066,358
2023-03-14 2023-03-13 S Sale
2.8
Farrington Thomas

EVP and CIO

Officer
200 -6.6%
35.59
US$7,118 		200 -6.6% 35.59 US$7,118
2023-03-14 2023-03-13 S Sale
2.8
Farrington Thomas

EVP and CIO

Officer
3,523 -53.8%
35.57
US$125,317 		3,523 -53.8% 35.57 US$125,317
2023-03-14 2023-03-10 S Sale
3.0
Dillard James E III

EVP & President CSCA

Officer
9,000 -26.4%
35.70
US$321,309 		9,000 -26.4% 35.70 US$321,309
2023-03-09 2023-03-08 S Sale
3.5
Janish Ronald Craig

EVP, Gbl Ops & SC & CTO

Officer
4,500 -18.2%
36.92
US$166,133 		4,500 -18.2% 36.92 US$166,133
2023-03-07 2023-03-06 B Purchase
1.9
Parker Geoffrey M.
Non-Executive Director
5,000 +46.0%
38.05
US$190,270 		5,000 +46.0% 38.05 US$190,270
2022-12-20 2022-12-16 S Sale
1.4
Quinn Grainne

EVP, Chief Medical Officer

Officer
2,368 -20.6%
31.65
US$74,947 		2,368 -20.6% 31.65 US$74,947
2022-03-16 2022-03-14 S Sale
2.8
Farrington Thomas

EVP and CIO

Officer
2,259 -100.0%
37.23
US$84,103 		2,259 -100.0% 37.23 US$84,103
2022-03-16 2022-03-14 S Sale
2.8
Farrington Thomas

EVP and CIO

Officer
24,485 -100.0%
37.13
US$909,079 		24,485 -100.0% 37.13 US$909,079
2022-03-08 2022-03-07 S Sale
3.5
Janish Ronald Craig

EVP, Gbl Ops & SC & CTO

Officer
3,954 -20.1%
36.73
US$145,232 		3,954 -20.1% 36.73 US$145,232
2021-12-20 2021-12-17 B Purchase
2.3
KINGMA TODD W

Executive VP, General Counsel

Officer
3,000 +6.1%
37.55
US$112,648 		3,000 +6.1% 37.55 US$112,648
2021-12-17 2021-12-16 B Purchase
1.9
Parker Geoffrey M.
Non-Executive Director
5,000 +85.0%
36.85
US$184,270 		5,000 +85.0% 36.85 US$184,270
2021-12-16 2021-12-16 B Purchase
3.4
Alford Bradley A
Non-Executive Director
13,000 +118.4%
36.88
US$479,409 		13,000 +118.4% 36.88 US$479,409
2021-12-07 2021-12-06 B Purchase
2.2
Andersen Svend

EVP & President CHCI

Officer
1,255 +10.1%
37.08
US$46,535 		1,255 +10.1% 37.08 US$46,535
2021-12-07 2021-12-06 B Purchase
2.2
Andersen Svend

EVP & President CHCI

Officer
2,400 +23.9%
37.11
US$89,064 		2,400 +23.9% 37.11 US$89,064
2021-12-06 2021-12-03 B Purchase
3.3
SILCOCK RAYMOND

EVP, Chief Financial Officer

Officer
27,500 +269.7%
36.03
US$990,930 		27,500 +269.7% 36.03 US$990,930
2021-12-03 2021-12-02 B Purchase
3.2
CLASSON ROLF A
Non-Executive Director
2,800 +19.1%
35.67
US$99,874 		2,800 +19.1% 35.67 US$99,874
2021-03-18 2021-03-17 B Purchase
1.9
Parker Geoffrey M.
Non-Executive Director
2,500 +1666.7%
41.29
US$103,218 		2,500 +1666.7% 41.29 US$103,218
2021-03-11 2021-03-10 S Sale
3.5
Janish Ronald Craig

EVP, Gbl Ops & SC & CTO

Officer
2,662 -18.5%
41.23
US$109,766 		2,662 -18.5% 41.23 US$109,766
2021-01-07 2021-01-06 PP Planned purchase
Sorota Richard S

EVP & President CSCA

Officer
7,513 +inf%
43.48
US$326,665 		7,513 +inf% 43.48 US$326,665
2020-11-10 2020-11-09 B Purchase
3.4
Samuels Theodore R. II
Non-Executive Director
4,500 +33.0%
46.91
US$211,112 		4,500 +33.0% 46.91 US$211,112
2020-11-10 2020-11-09 B Purchase
3.2
CLASSON ROLF A
Non-Executive Director
2,137 +24.5%
46.75
US$99,898 		2,137 +24.5% 46.75 US$99,898
2020-08-11 2020-08-11 B Purchase
2.2
Andersen Svend

EVP & President CHCI

Officer
2,828 +39.3%
53.01
US$149,910 		2,828 +39.3% 53.01 US$149,910
2020-05-11 2020-05-07 S Sale
2.8
Farrington Thomas

EVP and CIO

Officer
100 -0.7%
52.15
US$5,215 		100 -0.7% 52.15 US$5,215
2020-05-11 2020-05-07 S Sale
2.8
Farrington Thomas

EVP and CIO

Officer
404 -2.9%
52.14
US$21,065 		404 -2.9% 52.14 US$21,065
2020-05-11 2020-05-07 S Sale
2.8
Farrington Thomas

EVP and CIO

Officer
329 -2.3%
52.13
US$17,151 		329 -2.3% 52.13 US$17,151
2020-05-11 2020-05-07 S Sale
3.5
Janish Ronald Craig

EVP, Global Op. & Supply Chain

Officer
300 -3.4%
51.90
US$15,570 		300 -3.4% 51.90 US$15,570
2020-05-11 2020-05-07 S Sale
3.5
Janish Ronald Craig

EVP, Global Op. & Supply Chain

Officer
2,295 -20.5%
51.90
US$119,101 		2,295 -20.5% 51.90 US$119,101
2020-05-11 2020-05-07 S Sale
2.8
Farrington Thomas

EVP and CIO

Officer
1,167 -7.6%
52.12
US$60,824 		1,167 -7.6% 52.12 US$60,824
2020-03-17 2020-03-13 B Purchase
3.4
Samuels Theodore R. II
Non-Executive Director
2,000 +17.2%
42.50
US$85,000 		2,000 +17.2% 42.50 US$85,000
Explore more

More insider trading research around Perrigo Company PLC

More insider trades in IE
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity